Browse categories

Pancreatic Enzyme Replacement Therapy (PERT) Update 

Ongoing variability in the supply of pancreatic enzyme replacement therapy (PERT) — particularly Creon® 25,000iu capsules — has left some people struggling to obtain their prescription. We explain what manufacturers, the NHS and the Department of Health are doing, and where to turn for help.

Published: 3 weeks ago

By Leanne Talbot

Published: 3 weeks ago

By Leanne Talbot

Assessment of major gaps

Assessment of major gaps from the perspective of patients, patient advocates and NET health care professionals. Due to the increasing incidence and…

Published: 7 years ago

By Neuroendocrine Cancer UK

Published: 7 years ago

By Neuroendocrine Cancer UK

Neuroendocrine Tumours in the UK

British Journal of Cancer publishes first in-depth epidemiological characterisation of Neuroendocrine Tumours in the UK. British Journal of Cancer…

Published: 7 years ago

By Neuroendocrine Cancer UK

Published: 7 years ago

By Neuroendocrine Cancer UK

New Age for Nuclear Medicine

NEW AGE FOR NUCLEAR MEDICINE Radioactive drugs are not just diagnosing disease more effectively, they’re now being used for exciting new therapies. They…

Published: 7 years ago

By Neuroendocrine Cancer UK

Published: 7 years ago

By Neuroendocrine Cancer UK

Why this master of disguise needs careful handling

“NETs – Why this master of disguise needs careful handling” A fantastic INCA inspired article in Cancer World. Sophie Fessl hears from patients and…

Published: 7 years ago

By Neuroendocrine Cancer UK

Published: 7 years ago

By Neuroendocrine Cancer UK

SCAN 2019

SCAN 2019 This autumn the International Neuroendocrine Cancer Alliance INCA invites NET patients and healthcare professionals to scan the access…

Published: 7 years ago

By Neuroendocrine Cancer UK

Published: 7 years ago

By Neuroendocrine Cancer UK

‘I feel like I’m sitting on a time bomb’ – Kath reveals how incurable cancer affected her life

A woman with incurable cancer has spoken of how the disease has affected her life. Kath Lewis was diagnosed with neuroendocrine cancer in June 2015, just…

Published: 7 years ago

By Leanne Talbot

Published: 7 years ago

By Leanne Talbot

Assessment of major gaps from the perspective of patients, patient advocates and NET health care professionals

Due to the increasing incidence and prevalence of neuroendocrine tumors (NETs), there is a need to assess any gaps in awareness and care. A survey was…

Published: 7 years ago

By Leanne Talbot

Published: 7 years ago

By Leanne Talbot

British Journal of Cancer publishes first in-depth epidemiological characterisation of Neuroendocrine Tumours in the UK

British Journal of Cancer publishes NET Patient Foundation’s research into impact of neuroendocrine morphology on cancer outcome and stage at…

Published: 7 years ago

By Leanne Talbot

Published: 7 years ago

By Leanne Talbot

NEW AGE FOR NUCLEAR MEDICINE

Radioactive drugs are not just diagnosing disease more effectively, they’re now being used for exciting new therapies. They could be revolutionary in…

Published: 7 years ago

By Leanne Talbot

Published: 7 years ago

By Leanne Talbot